Document is current
Any future updates will be listed below
-
Authors
Alty, Jane
Goldberg, Lynette R.
Roccati, Eddy
Lawler, Katherine
Bai, Quan
Huang, Guan
Bindoff, Aidan D
Li, Renjie
Wang, Xinyi
St George, Rebecca J.
Rudd, Kaylee
Bartlett, Larissa
Collins, Jessica M.
Aiyede, Mimieveshiofuo
Fernando, Nadeeshani
Bhagwat, Anju
Giffard, Julia
Salmon, Katharine
McDonald, Scott
King, Anna E.
Vickers, James C.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council
Royal Hobart Hospital Research Foundation
University of Tasmania
- License Information
-
More Information
Article History
Received: 5 March 2024
Accepted: 21 March 2024
First Online: 16 April 2024
Declarations
:
: This research will be performed in accordance with the Declaration of Helsinki and has been approved by the Human Research Ethics Committee of the University of Tasmania, Australia, reference H0026879. The study is registered on ClinicalTrials.gov, with identifier NCT06114914. All participants will give written consent to participate [].
: No participant data is presented in this manuscript. All authors have given consent for publication. Consent has been obtained for publication of Fig. 2.
: JA receives royalties from Taylor and Francis publishing, has stock ownership in ClearSky Medical Diagnostics and has received Honoraria from Stada, Allergan, Merz, Medtronic and Nature Parkinsons Journal. All other authors have nothing to disclose.
